A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227B
Recruiting · NCT06441630 · Interventional (participants receive a specific treatment) · Lead sponsor: Addpharma Inc.
View the official record on ClinicalTrials.gov →Interventions studied
AD-227AAD-227BAD-227CPlacebo of AD-227BPlacebo of AD-227C
What this trial is about
The purpose of this study is to evaluate the efficacy and safety of co-administration of AD-227A and AD-227B in patients with essential hypertension
Who can take part
Age range
19 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 3
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Signed informed consent
- Patients with Essential Hypertension
- Other inclusions applied
Exclusion criteria
- Patient with Secondary Hypertension
- Other exclusions applied
Where it is running
1 location listed.
- Gangnam CHA Medical Center - Seoul, South Korea